Home » Newsletters » BioWorld Asia

BioWorld Asia

March 11, 1998

View Archived Issues

Transgène Seeks FFr420M In IPOs In France, US

bi03111998c.html

Trinity Turns Loss To Revenue; Buyouts Helped Bottom Line

Center Studying Vaccines For Rheumatic Fever, Malaria

Cantab's Revenues Double; R&D Program Set To Expand

Glaxo, Thallia Teaming Up For Microalgae-Based Drugs

PPL Expresses Blood-Clotting Agent In Transgenic Sheep Milk

Chinese Study Horse Drug As Human AIDS Vaccine

Amgen Supporting Cell Therapy Laboratory In France

EU 'Closely Follows' Ethics Of Gene-Based Diagnostics

Chiroscience Spins Off DNA Analysis Subsidiary

Agen Rebuffs A$16M Takeover Move By Biotech International

EU May Lend Support To Added Worldwide Rules On Cloning

British Biotech Losses 'In Line With Plan'

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...